Reggiani, P <br/><br/>
A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.  [electronic resource] 

 -  Transplantation proceedings  May 2005 
 - 1697-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2005.02.111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adrenal Cortex Hormones--adverse effects<br/>Adult<br/>Area Under Curve<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Liver Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Postoperative Period<br/>Survival Analysis<br/>Tacrolimus--therapeutic use